Abstract
Host defence, cationic antimicrobial peptides are now recognised as an important component, in most species, of the early innate and induced defences against invading microbes. They are small (12 to 35 amino acids), cationic due to the presence of an excess of arginine and lysine over acidic amino acids, and able to fold into a variety of different secondary structures. They have highly desirable properties, such as the ability to kill rapidly a broad spectrum of microorganisms including drug resistant bacteria and often fungi at around the minimal inhibitory concentration, a low level of resistance development in vitro, the ability to protect animals against both topical and systemic infections and the capability to neutralise endotoxin and demonstrated synergy with conventional antibiotics. In addition, given the 20 building blocks (amino acids) for these peptides, even a small peptide offers enormous diversity and potential for design of improved variants. For this reason such peptides have entered clinical trials, largely as agents for topical therapy of polymicrobial infections and are considered to have excellent potential for being a novel antibiotic class.
Similar content being viewed by others
References
Boman HG. Peptide antibiotics and their role in innate immunity. Annu Rev Immunol 1995; 13: 61–92
Ganz T, Lehrer RI. Antimicrobial peptides of leukocytes. Curr Opin Hematol 1997; 4: 53–8
Hancock REW, Falla T, Brown MM. Cationic bactericidal peptides. Adv Microb Physiol 1995; 37: 135–75
Hancock REW, Lehrer RI. Cationic peptides: a new source of antibiotics. Trends Biotech 1998; 16: 82–8
Kadalayil L, Petersen UM, Engstrom Y. Adjacent GATA and Kappa β-like motifs regulate the expression of a Drosophila immune gene. Nucl Acids Res 1997; 25: 1233–9
Hancock REW. Peptide antibiotics. Lancet 1997; 349: 418–22
Steinberg DA, Hurst MA, Fujii CA, et al. Protegrin-1: a broad spectrum, rapidly microbicidal peptide with in vivo activity. Antimicrob Agents Chemother 1997; 41: 1738–42
Kondejewski LH, Fanner SW, Wishart DS, et al. Gramicidin S is active against both gram-positive and gram-negative bacteria. Int J Peptein Prot Res 1996; 47: 460–6
Gough M, Hancock REW, Kelly NM. Anti-endotoxic potential of cationic peptide antimicrobials. Infect Immun 1996; 64: 4922–7
Hancock REW. Therapeutic potential of cationic peptides. Expert Opin Invest Dis 1998; 7: 167–74
Darveau RP, Cunningham MD, Seaford CL, et al. Beta-lactam antibiotics potentiate magainin 2 antimicrobial activity in vitro and in vivo. Antimicrob Agents Chemother 1991; 35: 1153–9
Rogy MA, Oldenburg HSA, Calvano SE, et al. The role of bactericidal/permeability-increasing protein in the treatment of primate bacteremia and septic shock. J Clin Immunol 1994; 14: 120–33
Appenzeller L, Lim E, Wong P, et al. In vivo fungicidal activity of optimized domain III peptides derived from bactericidal/ permeability-increasing protein BPI [abstract F187]. 36th International Conference on Antimicrobial Agents and Chemotherapy: 1996 Sep 17–20; New Orleans, 132
Nakashima H, Masuda M, Murakami T, et al. Anti-human immunodeficiency virus activity of a novel synthetic peptide, T22 ([Tyr-5,12, Lys-7] Polyphemusin II): a possible inhibitor of virus-cell fusion. Antimicrob Agents Chemother 1992; 36: 1249–55
Rodriguez MC, Zamudio F, Torres JA, et al. Effect of a cecropin-like synthetic peptide (Shiva -3) on the sporogenic development of Plasmodium berghei. Exp Parasitai 1995; 80: 596–604
Sawyer JG, Martin NL, Hancock REW. Interaction of macrophage cationic proteins with the outer membrane of Pseudomonas aeruginosa. Infect Immun 1988; 56: 693–8
Moore AJ, Devine DA, Bibby MC. Preliminary experimental anti-cancer activity of cecropin B. Peptide Res 1994; 7: 265–9
D’Cruz OJ, Periera A, Haas GG. Sperm immobilizing activity of a synthetic bioactive peptide 20–44 of 37-kDa cationic antimicrobial protein (CAP37) of human neutrophils. J Androl 1995; 16: 432–40
Jensen T, Pedersen SS, Garne S, et al. Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection. J Antimicrob Chemother 1987; 19: 831–8
Ahmad I, Perkins WR, Lupan DM, et al. Liposomal entrapment of the neutrophil-derived peptide indolicidin endows it with in vivo antifungal activity. Biochim Biophys Acta 1995; 1237: 109–14
Piers KL, Brown MH, Hancock REW. Recombinant DNA procedures for producing small antimicrobial cationic peptides in bacteria. Gene 1993; 134: 7–13
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hancock, R.E.W. Host Defence (bdCationic) Peptides. Drugs 57, 469–473 (1999). https://doi.org/10.2165/00003495-199957040-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199957040-00002